Brentuximab is a chimeric antibody targeting CD30 and is a naked antibody to Brentuximab vedotin.Brentuximab has antitumor activity and may be used to study relapsed or refractory Hodgkins lymphoma.
CAS Number:
[2088770-90-3]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted